Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints During Trump’s Oval Office Announcement

A White House press conference on Thursday was interrupted when a man fainted in the Oval Office. President Donald Trump was announcing an agreement with drug manufacturers to reduce the cost of obesity medications.

Incident Details and Public Reaction

The video showing the man collapsing quickly spread online. Independent journalist Eric Daugherty shared the footage, stating:

“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”
“Pray for him.”

Viewers who shared the video also expressed concern and offered prayers for the man’s well-being. The live feed was cut short as the incident occurred.

Mistaken Identity and Company Clarification

The man was initially identified as Gordon Findlay, with multiple sources claiming he was an executive at Novo Nordisk. One social media account posted:

“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”

However, Novo Nordisk later clarified this information:

“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”

Official Statement from the White House

White House Press Secretary Karoline Leavitt provided additional context:

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”

Summary

The individual who fainted during the announcement was not affiliated with Novo Nordisk, and the company hopes for his swift recovery.

Author’s summary: A man fainted during President Trump's announcement on lowering obesity drug costs; initially misidentified as a Novo Nordisk executive, the company denied involvement and wished him well.

more

Hindustan Times Hindustan Times — 2025-11-06